Autolus Therapeutics plc ADR (AUTL): Next-Year EPS Estimate 28.70%
As of 2026-06-04, Autolus Therapeutics plc ADR (AUTL) has a next-year EPS growth estimate of 28.70%.
On 2026-05-27, analyst consensus for AUTL's next-year EPS growth shifted from 29.74% to 28.70% — a negative change of 1.04 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 17.45%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.70%
- EPS growth this year
- 17.45%
- EPS next quarter (est)
- -$0.23
- Last price
- $1.66
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 28.70% | 17.45% | -$0.23 | $1.66 |
| 2026-06-03 | 28.70% | 17.45% | -$0.23 | $1.62 |
| 2026-06-02 | 28.70% | 17.45% | -$0.23 | $1.75 |
| 2026-06-01 | 28.70% | 17.45% | -$0.23 | $1.84 |
| 2026-05-31 | 28.70% | 17.45% | -$0.23 | $1.87 |
| 2026-05-28 | 28.70% | 17.45% | -$0.23 | $1.77 |
| 2026-05-27 | 28.70% | 17.45% | -$0.23 | $1.68 |
| 2026-05-26 | 29.74% | 17.52% | -$0.23 | $1.68 |
| 2026-05-25 | 29.74% | 17.52% | -$0.23 | $1.70 |
| 2026-05-24 | 29.74% | 17.52% | -$0.23 | $1.70 |
| 2026-05-21 | 29.74% | 17.52% | -$0.23 | $1.65 |
| 2026-05-20 | 29.74% | 17.52% | -$0.23 | $1.62 |
| 2026-05-19 | 29.74% | 17.52% | -$0.23 | $1.63 |
| 2026-05-18 | 29.74% | 17.52% | -$0.23 | $1.80 |
| 2026-05-17 | 29.74% | 17.52% | -$0.23 | $1.63 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Autolus Therapeutics plc ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Autolus Therapeutics plc ADR (AUTL) has a next-year EPS growth estimate of 28.70%, based on analyst consensus.
When was the latest EPS estimate revision for AUTL?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 29.74% to 28.70%.
What sector and industry does Autolus Therapeutics plc ADR belong to?▾
Autolus Therapeutics plc ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AUTL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Autolus Therapeutics plc ADR (AUTL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports